hypertension Flashcards
physiology of RAAS
liver synthesises angiotensinogen
angiotensinogen circulating in blood
less blood to brain –> stimulates sympathetic system –> stimulates beta 1 receptors in kidney –> renin is secreted –> converts angiotensinogen into angiotensin 1 –> ACE by endothelial cells of lungs converts angiotensin 1 to angiotensin 2
Angiotensin 2 acts on AT1 receptors present on various organs and increases Bp
angiotensin 2 receptor
acts on AT1 receptors on various organs and increases BP
1. adrenal cortex -> increases aldosterone secretion (Na+ reabsorption - increases BP, K+ loss - hypokalaemia)
- blood vessels - arteries and veins - constriction
- heart - cardiac hypertrophy - oxygen demands increase - leads to chronic heart failure
RAAS inhibitors
- direct renin inhibitors (-iren)
- ACE inhibitors (-pril)
- AT1 receptor inhibitors (-sartan)
MoA of RAAS inhibitors
- reduce aldosterone secretion - Na+ loss in urine - diuretic
(SE - hyperkalemia) - Artery and vein - dilator
- Heart - reduce cardiac hypertrophy (cardioprotective effect - given in chronic heart failure)
RAAS inhibitors should be avoided with which diuretic
K+ sparing diuretics
Both produce hyperkalemia
drugs which reduce renin secretion from kidney
beta blockers
central sympatholytics - Clonidine, alpha methyl dopa
Also produce hyperkalemia
drugs causing hyperkalemia
ABC CNS
alpha methyl dopa
beta blocker
clonidine
cyclosporine /tacrolimus - immunosuppressive agents
NSAID
spironolactone (K+ sparing diuretic)
RAAS inhibitors
direct renin inhibitors
Aliskiren (only approved drug) - binds to renin and renin can no longer work
Remikiren, Enalkiren (under trial)
Aliskiren
oral
use - as an anti hypertensive
SE & CI - same as ACE inhibitors
adv - does not increase bradykinin level (done by ACE inhibitors)
ACE inhibitors
location - endothelial cells of blood vessels in lungs
non specific carboxypeptidase enzyme
increases bradykinin level -
adv: bradykinin is a vasodilator and decreases blood pressure -> thus, ACE inhibitors have additional antihypertensive effect
disadvantage: causes allergy (DARU)
dry cough
angioedema
rhinitis
urticaria
functions of ACE
- breaks down angiotensin 1 (10 amino acids) into angiotensin 2 (8 amino acids)
- degrades bradykinin
SE of ACE inhibitors
dry cough is the most common SE of ACE inhibitors (incidence - 15%)
angioedema
rhinitis
urticaria
treatment of ACE inhibitor in diced dry cough
stop ACE inhibitors and change to sartans which do not increase bradykinin (best treatment)
aspirin + iron is found to be effective to control dry cough
ACE inhibitor drugs
CRPF BELT QM
Captopril - 1st discovered
Ramipril
Perindopril
Fosinopril
Benazepril
Enalapril
Lisinopril
Trandalopril
Quinapril
Moxepril
Captopril disadvantage
sulpha drug - bone marrow depression
shortest drug - twice/day
food reduces absorption
thus, rarely used now
other drugs -
no sulpha
long acting - once/day
no food interaction
longest ACE inhibitor
Perindopril > Ramipril
ACE inhibitor which does not require dose reduction in renal failure
Fosinopril (excreted in bile also)
ACE inhibitor which is pro drug
All ACE inhibitors are pro drugs except
Captopril
Lisinopril
Enalaprilat (active form of Enalapril)
active form of Enalapril
Enalapril (oral) ——-> Enalaprilat (iv drug) - used in hypertensive emergencies
uses of ACE inhibitors
- DOC hypertension (essential hypertension)
- DOC hypertension + DM - does not interfere with blood glucose, HTN + CKD (nephropathy) - renoprotective effect, HTN + retinopathy - retinoprotective effect, HTN + stroke - neuroprotective effect, HTN + scleroderma - reduces collagen deposition
- DOC CHF - reduces cardiac hypertrophy
renoprotective effect of ACE inhibitors in CKD
here, CKD - albuminuria (because usually kidney cannot filter albumin)
hyper filtration of living nephrons (increased GFR) –> albumin is filtered –> damage nephrons –> vicious cycle –> end stage renal disease
ACE inhibitors dilate efferent arterioles –> slightly reduce GFR –> reduce hyperalbuminuria –> reduce albuminuria –> reduce damage of nephrons
CI of ACE inhibitors
bilateral afferent renal artery stenosis
GFR become extremely low and will lead to oliguria and ARF
should not be combined with NSAIDs (constricts afferent arterioles)
also CI in pregnancy (Category X drug) - renal agenesis in foetus - oliguhydramnios –> pulmonary hypoplasia (Potter sequence)
Summary of ACE inhibitor
CAPTOPRIl
Cough - bradykinin
Angioedema - bradykinin
Pregnancy (no) - X category
Taste disturbance - dysguesia - seen with Captopril (sulpha)
Orthostatic hypotension
Prodrugs (except Captopril and Lisinopril)
Renal afferent artery stenosis CI
Increase K+ - hyperkalemia
Low blood count - bone marrow suppression (mainly seen with Captopril)
Angiotensin receptors
AT1 - AT5 (All are GPCR)
AT1 - Gq type-excitatory - increases BP
AT2-Gi type - decreases BP
Block AT1 to decrease BP